Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 23 Breast Neoplasms 14 Neoplasms 7 Carcinoma, Ovarian Epithelial 6 Testicular Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Fatigue 5 Burkitt Lymphoma 5 Blast Crisis 5 Urinary Bladder Neoplasms 4 Primary Myelofibrosis 4 Neuroblastoma 4 Multiple Myeloma 4 Leukemia, Myeloid, Acute 4 Leukemia, Hairy Cell 4 Depression 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 3 Myeloproliferative Disorders 3 Lymphoma, T-Cell, Cutaneous 3 Lung Neoplasms 3

Interventions

Gemcitabine 9 pembrolizumab 7 Cisplatin 5 enfortumab vedotin 4 atezolizumab 4 Trastuzumab 4 Mitomycin 4 Carboplatin 4 Sunitinib 3 Pemetrexed 3 dodecyl maltoside 2 cabozantinib 2 Water 2 Sugammadex 2 Standard of Care 2 Saline Solution 2 Paclitaxel 2 Nivolumab 2 Neostigmine 2 Docetaxel 2 Cetuximab 2 Bevacizumab 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 vinflunine 1 valrubicin 1 tucatinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Therapeutics × Genitourinary × Clear all

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡